share_log

华康股份(605077.SH):构建华康合成生物学核心技术研发体系

Huakang Co., Ltd. (605077.SH): Establishing a core technology research and development system for Huakang synthetic biology

Gelonghui Finance ·  May 20 06:35

Gelonghui, May 20 | Huakang Co., Ltd. (605077.SH) said on the investor interactive platform that the Synthetic Biology Joint Innovation Research and Development Center, which was jointly built with Academician Zheng Yuguo's team of Zhejiang University of Technology in 2023, relies on academician research teams to focus on synthetic biology research. At the unveiling ceremony of Huakang Co., Ltd. and the Synthetic Biology Joint Innovation Research and Development Center of Zhejiang University of Technology, Academician Zheng Yuguo pointed out that the rise and progress of synthetic biology research will bring new opportunities for the development of nutritional and health industries such as Huakang's functional sugar alcohol. Zhejiang University of Technology and Huakang have jointly built a synthetic biology innovation research and development center through industrial project development and implementation, combining the guiding idea of “simplifying complex problems” in the engineering amplification process to achieve efficient linkage between the robustness of industrial chassis cell construction and large-scale production, and establish a core technology research and development system for Huakang synthetic biology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment